These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

77 related articles for article (PubMed ID: 7271342)

  • 21. Growth factors G-CSF and GM-CSF differentially preserve chemotaxis of neutrophils aging in vitro.
    Wolach B; van der Laan LJ; Maianski NA; Tool AT; van Bruggen R; Roos D; Kuijpers TW
    Exp Hematol; 2007 Apr; 35(4):541-50. PubMed ID: 17379064
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Measles vaccine in the People's Republic of China.
    Xiang JZ; Chen ZH
    Rev Infect Dis; 1983; 5(3):506-10. PubMed ID: 6879006
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Safety and immunogenicity of concurrent administration of live attenuated influenza vaccine with measles-mumps-rubella and varicella vaccines to infants 12 to 15 months of age.
    Nolan T; Bernstein DI; Block SL; Hilty M; Keyserling HL; Marchant C; Marshall H; Richmond P; Yogev R; Cordova J; Cho I; Mendelman PM;
    Pediatrics; 2008 Mar; 121(3):508-16. PubMed ID: 18310199
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Live attenuated measles and mumps viral strain-containing vaccines and hearing loss: Vaccine Adverse Event Reporting System (VAERS), United States, 1990--2003.
    Asatryan A; Pool V; Chen RT; Kohl KS; Davis RL; Iskander JK;
    Vaccine; 2008 Feb; 26(9):1166-72. PubMed ID: 18255204
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Aseptic meningitis after vaccination against measles and mumps.
    Cizman M; Mozetic M; Radescek-Rakar R; Pleterski-Rigler D; Susec-Michieli M
    Pediatr Infect Dis J; 1989 May; 8(5):302-8. PubMed ID: 2726323
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Persistence of antibody after administration of monovalent and combined live attenuated measles, mumps, and rubella virus vaccines.
    Weibel RE; Buynak EB; McLean AA; Hilleman MR
    Pediatrics; 1978 Jan; 61(1):5-11. PubMed ID: 263873
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Inhibitory effect of prostaglandin A1 on neutrophil motility.
    Rabson AR; Anderson R; Glover A; Lomnitzer R
    Br J Exp Pathol; 1978 Jun; 59(3):298-304. PubMed ID: 678445
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effect of simultaneous administration of live measles vaccine on the "take rate" of live mumps vaccine.
    André FE; Peetermans J
    Dev Biol Stand; 1986; 65():101-7. PubMed ID: 3556770
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Selective inhibition of human neutrophil chemotaxis to N-formyl-methionyl-leucyl-phenylalanine by sulfones.
    Harvath L; Yancey KB; Katz SI
    J Immunol; 1986 Aug; 137(4):1305-11. PubMed ID: 3016092
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Specific prevention of measles in Rumania. V. Studies on an attenuated live measles virus vaccine prepared at the Stefan S. Nicolau Institute of Virology and administered in various ways].
    Cajal N; Cepleanu M; Cernesc C; Sorodoc Y; Tigăeru N; Biberi-Moroianu S; Cuciu D; Brebenel G; Vucu E; Petrescu A
    Stud Cercet Virusol; 1973; 24(5):349-56. PubMed ID: 4747453
    [No Abstract]   [Full Text] [Related]  

  • 31. Measles vaccination: new strategies and formulations.
    de Vries RD; Stittelaar KJ; Osterhaus AD; de Swart RL
    Expert Rev Vaccines; 2008 Oct; 7(8):1215-23. PubMed ID: 18844595
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Development of measles vaccines in Japan.
    Ueda S
    Vaccine; 2009 May; 27(24):3230-1. PubMed ID: 19446197
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [The cell-mediated response after measles vaccination].
    Pala S; Crimaldi G; Consolini R; Macchia P
    Pediatr Med Chir; 1998; 20(3):213-6. PubMed ID: 9744016
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Inhibition of human neutrophil chemotaxis toward interleukin 8 with six clinical antithrombin concentrates in vitro.
    Kaneider NC; Rabensteiner A; Reinisch CM; Dunzendorfer S; Wiedermann CJ
    Intensive Care Med; 2002 Oct; 28(10):1447-52. PubMed ID: 12373470
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Inhibiting effect of low density lipoproteins (LDL) on neutrophil function (author's transl)].
    De Martino M; Vierucci A; Redi Orienti M; Biadaioli R; Novembre E
    Ann Sclavo; 1979; 21(3):354-61. PubMed ID: 233063
    [TBL] [Abstract][Full Text] [Related]  

  • 36. In vitro and in vivo effects of granulocyte colony-stimulating factor on neutrophils in glycogen storage disease type 1B: granulocyte colony-stimulating factor therapy corrects the neutropenia and the defects in respiratory burst activity and Ca2+ mobilization.
    McCawley LJ; Korchak HM; Douglas SD; Campbell DE; Thornton PS; Stanley CA; Baker L; Kilpatrick L
    Pediatr Res; 1994 Jan; 35(1):84-90. PubMed ID: 7510873
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Evidence of recombination among early-vaccination era measles virus strains.
    Schierup MH; Mordhorst CH; Muller CP; Christensen LS
    BMC Evol Biol; 2005 Oct; 5():52. PubMed ID: 16209713
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Attenuated, oncolytic, but not wild-type measles virus infection has pleiotropic effects on human neutrophil function.
    Zhang Y; Patel B; Dey A; Ghorani E; Rai L; Elham M; Castleton AZ; Fielding AK
    J Immunol; 2012 Feb; 188(3):1002-10. PubMed ID: 22180616
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Use of a vaccine strain of measles virus genetically engineered to produce carcinoembryonic antigen as a novel therapeutic agent against glioblastoma multiforme.
    Phuong LK; Allen C; Peng KW; Giannini C; Greiner S; TenEyck CJ; Mishra PK; Macura SI; Russell SJ; Galanis EC
    Cancer Res; 2003 May; 63(10):2462-9. PubMed ID: 12750267
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Measles immunization and its problems].
    Kökkaya A
    Mikrobiyol Bul; 1982 Jan; 16(1):66-70. PubMed ID: 7144618
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.